{"id":"NCT02348489","sponsor":"Astex Pharmaceuticals, Inc.","briefTitle":"SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction","officialTitle":"A Phase 3, Multicenter, Open-label, Randomized Study of SGI-110 Versus Treatment Choice (TC) in Adults With Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Considered Candidates for Intensive Remission Induction Chemotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-03-19","primaryCompletion":"2018-05-31","completion":"2019-06-17","firstPosted":"2015-01-28","resultsPosted":"2021-01-14","lastUpdate":"2024-08-27"},"enrollment":815,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Leukemia, Myeloid, Acute"],"interventions":[{"type":"DRUG","name":"SGI-110 (guadecitabine)","otherNames":[]},{"type":"DRUG","name":"Treatment Choice","otherNames":[]}],"arms":[{"label":"SGI-110 (guadecitabine)","type":"EXPERIMENTAL"},{"label":"Treatment Choice","type":"ACTIVE_COMPARATOR"}],"summary":"To compare efficacy and safety between SGI-110 and Treatment Choice in adults with previously untreated AML who are not considered candidates for intensive remission induction chemotherapy.","primaryOutcome":{"measure":"Number of Participants With a Complete Response (CR)","timeFrame":"Up to 38 months (median follow-up of 25.5 months)","effectByArm":[{"arm":"SGI-110 (Guadecitabine)","deltaMin":79,"sd":null},{"arm":"Treatment Choice","deltaMin":71,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.482"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":135,"countries":["United States","Australia","Austria","Belgium","Bulgaria","Canada","Czechia","Denmark","Finland","France","Germany","Hungary","Italy","Japan","Netherlands","Poland","Romania","Russia","Serbia","South Korea","Spain","Sweden","Taiwan","United Kingdom"]},"refs":{"pmids":["37276510"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":327,"n":401},"commonTop":["Constipation","Thrombocytopenia","Diarrhea","Neutropenia","Nausea"]}}